Longaeva Partners’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMMX
SVCM
OM
Longaeva Partners's IMMX Position: Q3 2026 in Review
Longaeva Partners opened a new position in Immix Biopharma (IMMX) in Q3 2026: 318,181 shares worth $3.31M. The stake represents 0.07% of the portfolio and ranks #213 among its holdings. This is a return to the name: Longaeva Partners previously reported a position in IMMX as recently as Q4 2025.
Longaeva Partners first reported a position in IMMX in Q4 2025 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.
- Longaeva Partners held 318,181 shares of Immix Biopharma worth $3.31M as of Q3 2026.
- Immix Biopharma was a new Longaeva Partners position in Q3 2026.
- Immix Biopharma made up 0.07% of Longaeva Partners's portfolio in Q3 2026, its #213 holding.
- Longaeva Partners first reported a position in Immix Biopharma in Q4 2025 and has held it in 2 quarters since.
- 137 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.